These results are consistent with other preclinical pancreatic cancer tumor models of low-dose radiation and CAR T cells enhancing antitumor responses, in part due to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [38]. The gene discussed is TNFSF10; the disease is familial pancreatic carcinoma.